Roswell Park exploring more Cuban vaccines
Just six weeks after announcing a lung cancer vaccine development deal with a Cuban cancer research center, officials from Roswell Park Cancer Institute are looking at several more vaccine opportunities in the country.
While it works to complete an investigational new drug (IND) application with the U.S. Food & Drug Administration, a group from Roswell Park will travel to Cuba in July to explore additional opportunities.
“There’s lots of enthusiasm,” said Candace Johnson, CEO. “We’re…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Tracey Drury Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cuba Health | Health | Health Management | Investigational New Drugs | Lung Cancer | Pharmaceuticals | Vaccines